[{"address1": "4870 Sadler Road", "address2": "Suite 300", "city": "Glen Allen", "state": "VA", "zip": "23060", "country": "United States", "phone": "(804) 487-8196", "website": "https://www.adial.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Glen Allen, Virginia.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Mr. Cary John Claiborne MBA", "age": 63, "title": "CEO, President & Director", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 561331, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tony  Goodman", "age": 60, "title": "COO & Director", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 328500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Vinay  Shah A.C.A., M.B.A.", "age": 61, "title": "CFO & Treasurer", "yearBorn": 1963, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John R. Martin J.D.", "title": "Chief Legal Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Andrew  Taubman", "title": "Vice President of Corporate Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Brigette  Robertson M.D.", "age": 60, "title": "Acting Chief Medical Officer", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Abel  Svitavsky CPA", "title": "Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.7169, "open": 0.7112, "dayLow": 0.68, "dayHigh": 0.7299, "regularMarketPreviousClose": 0.7169, "regularMarketOpen": 0.7112, "regularMarketDayLow": 0.682, "regularMarketDayHigh": 0.7299, "payoutRatio": 0.0, "beta": 1.258, "forwardPE": -0.51578945, "volume": 18017, "regularMarketVolume": 18017, "averageVolume": 803132, "averageVolume10days": 54090, "averageDailyVolume10Day": 54090, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 4510168, "fiftyTwoWeekLow": 0.58, "fiftyTwoWeekHigh": 3.0, "fiftyDayAverage": 0.7346, "twoHundredDayAverage": 0.9549, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 759642, "profitMargins": 0.0, "floatShares": 6146385, "sharesOutstanding": 6574590, "sharesShort": 417407, "sharesShortPriorMonth": 685273, "sharesShortPreviousMonthDate": 1740700800, "dateShortInterest": 1743379200, "sharesPercentSharesOut": 0.0635, "heldPercentInsiders": 0.01397, "heldPercentInstitutions": 0.09719, "shortRatio": 5.08, "shortPercentOfFloat": 0.0644, "impliedSharesOutstanding": 6574590, "bookValue": 0.628, "priceToBook": 1.0923567, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -13197451, "trailingEps": -2.72, "forwardEps": -1.33, "lastSplitFactor": "1:25", "lastSplitDate": 1691366400, "enterpriseToEbitda": -0.092, "52WeekChange": -0.63684213, "SandP52WeekChange": 0.05430484, "quoteType": "EQUITY", "currentPrice": 0.686, "targetHighPrice": 7.0, "targetLowPrice": 6.0, "targetMeanPrice": 6.5, "targetMedianPrice": 6.5, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 3750525, "totalCashPerShare": 0.57, "ebitda": -8283892, "totalDebt": 0, "quickRatio": 3.843, "currentRatio": 4.159, "returnOnAssets": -1.05879, "returnOnEquity": -3.238, "freeCashflow": -3994250, "operatingCashflow": -6922306, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ADIL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "epsTrailingTwelveMonths": -2.72, "epsForward": -1.33, "epsCurrentYear": -1.74667, "priceEpsCurrentYear": -0.39274734, "fiftyDayAverageChange": -0.048600018, "fiftyDayAverageChangePercent": -0.06615848, "twoHundredDayAverageChange": -0.26890004, "twoHundredDayAverageChangePercent": -0.2816002, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "shortName": "Adial Pharmaceuticals, Inc", "cryptoTradeable": false, "longName": "Adial Pharmaceuticals, Inc.", "corporateActions": [], "postMarketTime": 1744925335, "regularMarketTime": 1744920001, "exchange": "NCM", "messageBoardId": "finmb_112638788", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -4.310225, "regularMarketPrice": 0.686, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1532698200000, "postMarketChangePercent": 6.38484, "postMarketPrice": 0.7298, "postMarketChange": 0.0438, "regularMarketChange": -0.030900002, "regularMarketDayRange": "0.682 - 0.7299", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 803132, "fiftyTwoWeekLowChange": 0.106000006, "fiftyTwoWeekLowChangePercent": 0.18275863, "fiftyTwoWeekRange": "0.58 - 3.0", "fiftyTwoWeekHighChange": -2.3140001, "fiftyTwoWeekHighChangePercent": -0.7713334, "fiftyTwoWeekChangePercent": -63.68421, "earningsTimestamp": 1741095000, "earningsTimestampStart": 1747080000, "earningsTimestampEnd": 1747425600, "isEarningsDateEstimate": true, "displayName": "Adial Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-04-19"}]